Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Infleqtion, Inc.
13D/A
INFQ · 45676K103
|
3.6% |
5/26/2026
Event 5/21/2026
|
|||
| MCV Management Company, LLC | 3.6% | ||||
| Maverick Capital Management, LLC | 3.6% | ||||
| Maverick Ventures Investment Fund, L.P. | 2.3% | ||||
| Maverick Advisors Fund, L.P. | 1.4% | ||||
| Maverick Capital Ventures, LLC | 3.6% | ||||
| Maverick Silicon Fund, L.P. | 0% | ||||
| Maverick Fund USA, Ltd. | 0% | ||||
| Maverick Designated Investments Fund, L.P. | 0% | ||||
| Maverick Long Fund, Ltd. | 0% | ||||
| Maverick Long Enhanced Fund, Ltd. | 0% | ||||
| Maverick Fund II, Ltd. | 0% | ||||
| Maverick Capital, Ltd. | 3.6% | ||||
| Lee S. Ainslie III | 3.6% | ||||
| David B. Singer | 3.6% | ||||
| Maverick Silicon, L.P. | 0% | ||||
|
Peabody Energy Corporation
13G/A
BTU · 704551100
|
3.3% |
2/13/2026
Event 12/31/2025
|
|||
| Maverick Capital, Ltd. | 3.3% | ||||
| Maverick Capital Management, LLC | 3.3% | ||||
| Lee S. Ainslie III | 3.3% | ||||
|
Rocket Pharmaceuticals, Inc.
13G/A
RCKT · 77313F106
|
2.3% |
2/13/2026
Event 12/31/2025
|
|||
| Maverick Capital, Ltd. | 2.3% | ||||
| Maverick Capital Management, LLC | 2.3% | ||||
| Lee S. Ainslie III | 2.3% | ||||
|
Invivyd, Inc.
13G/A
IVVD · 00534A102
|
6.7% |
2/13/2026
Event 12/31/2025
|
|||
| Maverick Capital, Ltd. | 6.7% | ||||
| Maverick Capital Management, LLC | 6.7% | ||||
| Lee S. Ainslie III | 6.7% | ||||
|
Fractyl Health, Inc.
13G/A
GUTS · 35168W103
|
3.1% |
11/14/2025
Event 9/30/2025
|
|||
| Maverick Capital, Ltd. | 3.1% | ||||
| Maverick Capital Management, LLC | 3.1% | ||||
| Lee S. Ainslie III | 3.1% | ||||
|
Curis, Inc.
13G/A
CRIS · 231269309
|
0.4% |
11/14/2025
Event 9/30/2025
|
|||
| Maverick Capital, Ltd. | 0.4% | ||||
| Maverick Capital Management, LLC | 0.4% | ||||
| Lee S. Ainslie III | 0.4% | ||||
|
Verona Pharma Plc
13G/A
VRNA · 925050106
|
3.8% |
2/14/2025
Event 12/31/2024
|
|||
| Maverick Capital, Ltd. | 3.8% | ||||
| Maverick Capital Management, LLC | 3.8% | ||||
| Lee S. Ainslie III | 3.8% | ||||
|
Wave Life Sciences Ltd.
13G/A
WVE · Y95308105
|
5.4% |
2/14/2025
Event 12/31/2024
|
|||
| Maverick Capital, Ltd. | 5.4% | ||||
| Maverick Capital Management, LLC | 5.4% | ||||
| Lee S. Ainslie III | 5.4% | ||||